About Oviva
Oviva is Europe's leading digital health provider for weight-related conditions, making evidence-based care accessible to everyone who needs it—reimbursed, at scale, and proven. Founded in 2014 by Kai Eberhardt and Manuel Baumann, the company has significantly improved the lives of more than 1 million patients across Germany, the UK, and Switzerland, backed by 100+ peer-reviewed publications. Oviva's AI-enabled care combines a medical-device-certified app with clinical teams of doctors, dietitians, and behavioural specialists. The platform provides personalised dietary advice combined with unique digital tools to help patients change their habits and improve their health long-term. The company's approach is reimbursed as a certified DiGA (Digital Health Application) in Germany, delivered in partnership with the NHS in the UK, and integrated into Swiss public healthcare. The company treats obesity, hypertension, and type 2 diabetes, expanding further to become the long-term partner for chronic care in Europe. Oviva's services include digital Tier 3 Weight Management, NHS Diabetes Prevention Programme, diabetes remission services, and virtual clinics offering medical support therapy. With over 420 experienced dietitians, psychologists, and doctors, Oviva maintains a 97% recommendation rate from patients. The company operates across multiple European markets with offices in Zurich, Altendorf, London, Berlin, Potsdam, and Warsaw.
Mission & Story
Mission
To build a healthier future for all, our mission is to provide the most accessible and effective care to people living with weight-related conditions
Founding Story
Founded in 2014 by Kai Eberhardt (ex-Junior Partner at McKinsey) and Manuel Baumann (ex-Accenture with 15+ years engineering experience). The company employed its first dietitian in Switzerland and treated its first patient supported by their app in the founding year.
Clinical Focus
Medical conditions and clinical areas addressed by Oviva.
Who It Serves
Milestones & Awards
Recent Milestones
Surpassed 1 million patients treated (July 2025). Secured €200 million Series D funding (January 2026). Hypertension DiGA approved by BfArM (January 2026). Reached 124,700 prescriptions in 2024, ranking #1 in DiGA market. Launched virtual Oviva Clinics in UK and Switzerland (2024). Expanded to weight loss medication support services.
Awards & Recognition
2022 HSJ Partnerships Award for 'Most impactful project addressing health inequalities'. TTG50 Winner: Health Tech Tour Growth 50 2022. Digital Health 150 CB Insights 2021. Forum of Managed Care (FMC) first prize (2018). Recognized as 'Model of Good Practice' by Swiss Federal Office of Public Health (2018).
Key Partnerships
Social & Media
Latest Updates
Company Details
- Founded
- 2014
- Headquarters
- Zurich, Switzerland
- Employees
- 201-500
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.